Frequent occurrence of non-malignant genetic alterations in clinical grade mesenchymal stromal cells expanded for cell therapy protocols
Chiara Capelli,
Olga Pedrini,
Gisella Cassina,
Orietta Spinelli,
Silvia Salmoiraghi,
Josée Golay,
Alessandro Rambaldi,
Ursula Giussani,
Martino Introna
Affiliations
Chiara Capelli
USS Center of Cellular Therapy “G. Lanzani”, A.O. Papa Giovanni XXIII, Bergamo, Italy;USSD Laboratorio di Genetica Medica, A.O. Papa Giovanni XXIII, Bergamo, Italy;USC Hematology, A.O. Papa Giovanni XXIII, Bergamo, Italy
Olga Pedrini
USS Center of Cellular Therapy “G. Lanzani”, A.O. Papa Giovanni XXIII, Bergamo, Italy;USSD Laboratorio di Genetica Medica, A.O. Papa Giovanni XXIII, Bergamo, Italy;USC Hematology, A.O. Papa Giovanni XXIII, Bergamo, Italy
Gisella Cassina
USSD Laboratorio di Genetica Medica, A.O. Papa Giovanni XXIII, Bergamo, Italy
Orietta Spinelli
USC Hematology, A.O. Papa Giovanni XXIII, Bergamo, Italy
Silvia Salmoiraghi
USC Hematology, A.O. Papa Giovanni XXIII, Bergamo, Italy
Josée Golay
USS Center of Cellular Therapy “G. Lanzani”, A.O. Papa Giovanni XXIII, Bergamo, Italy;USSD Laboratorio di Genetica Medica, A.O. Papa Giovanni XXIII, Bergamo, Italy;USC Hematology, A.O. Papa Giovanni XXIII, Bergamo, Italy
Alessandro Rambaldi
USC Hematology, A.O. Papa Giovanni XXIII, Bergamo, Italy
Ursula Giussani
USSD Laboratorio di Genetica Medica, A.O. Papa Giovanni XXIII, Bergamo, Italy
Martino Introna
USS Center of Cellular Therapy “G. Lanzani”, A.O. Papa Giovanni XXIII, Bergamo, Italy;USSD Laboratorio di Genetica Medica, A.O. Papa Giovanni XXIII, Bergamo, Italy;USC Hematology, A.O. Papa Giovanni XXIII, Bergamo, Italy
